Beauvericin (BEA), a cyclic hexadepsipeptide from Codyceps cicadae, possesses anti-convulsion, anti-
arrhythmia, sedation, and anti-
tumor activities. It has been reported that BEA induces apoptosis in several
cancer cell lines. However, the molecular mechanism underlying the BEA-induced apoptotic process is not yet clearly understood. In the present study, the intracellular signaling pathways of BEA-induced apoptosis in human
non-small cell lung cancer (NSCLC) A549 cells were investigated using morphological analysis and
terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) technique. In this study, BEA-induced apoptosis in human NSCLC A549 cells demonstrated a BEA concentration- and treatment time-dependent manner. This BEA-induced apoptosis in human NSCLC A549 cells was also accompanied by the up-regulation of Bax, Bak, and p-Bad and down-regulation of p-Bcl-2, but no effect on the levels of Bcl-X(L) or Bad
proteins. Moreover, the BEA treatment resulted in a significant reduction of mitochondrial membrane potential, increase in the release of mitochondrial
cytochrome c (cyt c), and activation of
caspase 3. Furthermore, treatment with
caspase 3 inhibitor (
z-DEVD-fmk) was capable to prevent the BEA-induced
caspase 3 activity and cell death. These results clearly demonstrate that the induction of apoptosis by BEA involves multiple cellular/molecular pathways and strongly suggest that pro- and anti-apoptotic Bcl-2 family
proteins, mitochondrial membrane potential, mitochondrial cyt c, and
caspase 3, they all participate in BEA-induced apoptotic process in human NSCLC A549 cells.